Manulife (Manufacturers Life Insurance)’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-36,401
| Closed | -$734K | – | 3205 |
|
|
2021
Q3 | $734K | Sell |
36,401
-2,668
| -7% | -$73.7K | ﹤0.01% | 2023 |
|
|
2021
Q2 | $1.46M | Buy |
39,069
+1,552
| +4% | +$47.6K | ﹤0.01% | 1764 |
|
|
2021
Q1 | $959K | Sell |
37,517
-2,416
| -6% | -$61.7K | ﹤0.01% | 1914 |
|
|
2020
Q4 | $880K | Buy |
39,933
+1,754
| +5% | +$38.6K | ﹤0.01% | 1895 |
|
|
2020
Q3 | $687K | Sell |
38,179
-680
| -2% | -$14.1K | ﹤0.01% | 1840 |
|
|
2020
Q2 | $961K | Buy |
38,859
+4,919
| +14% | +$106K | ﹤0.01% | 1638 |
|
|
2020
Q1 | $623K | Buy |
33,940
+2,224
| +7% | +$43.2K | ﹤0.01% | 1729 |
|
|
2019
Q4 | $699K | Sell |
31,716
-1,342
| -4% | -$27K | ﹤0.01% | 1863 |
|
|
2019
Q3 | $502K | Hold |
33,058
| – | – | ﹤0.01% | 2012 |
|
|
2019
Q2 | $521K | Sell |
33,058
-2,988
| -8% | -$40.6K | ﹤0.01% | 2025 |
|
|
2019
Q1 | $528K | Buy |
36,046
+4,543
| +14% | +$52.2K | ﹤0.01% | 2053 |
|
|
2018
Q4 | $336K | Buy |
31,503
+870
| +3% | +$11.4K | ﹤0.01% | 2130 |
|
|
2018
Q3 | $468K | Sell |
30,633
-3,804
| -11% | -$55.4K | ﹤0.01% | 2343 |
|
|
2018
Q2 | $422K | Buy |
34,437
+32,612
| +1,787% | +$410K | ﹤0.01% | 2526 |
|
|
2018
Q1 | $17K | Buy |
1,825
+1,019
| +126% | +$11K | ﹤0.01% | 3795 |
|
|
2017
Q4 | $7K | Buy |
+806
| New | +$5.93K | ﹤0.01% | 4080 |
|
|
2017
Q3 | – | Sell |
-642
| Closed | -$2K | – | 4394 |
|
|
2017
Q2 | $2K | Sell |
642
-29
| -4% | -$92 | ﹤0.01% | 4155 |
|
|
2017
Q1 | $2K | Hold |
671
| – | – | ﹤0.01% | 3974 |
|
|
2016
Q4 | $2K | Hold |
671
| – | – | ﹤0.01% | 4143 |
|
|
2016
Q3 | $4K | Hold |
671
| – | – | ﹤0.01% | 3965 |
|
|
2016
Q2 | $2K | Sell |
671
-10,395
| -94% | -$42.7K | ﹤0.01% | 4038 |
|
|
2016
Q1 | $57K | Buy |
11,066
+861
| +8% | +$5.43K | ﹤0.01% | 3251 |
|
|
2015
Q4 | $121 | Hold |
10,205
| – | – | ﹤0.01% | 3003 |
|
|
2015
Q3 | $83 | Buy |
10,205
+428
| +4% | +$4.94K | ﹤0.01% | 3201 |
|
|
2015
Q2 | $136 | Buy |
9,777
+9,161
| +1,487% | +$168K | ﹤0.01% | 3178 |
|
|
2015
Q1 | $15 | Hold |
616
| – | – | ﹤0.01% | 3500 |
|
|
2014
Q4 | $10 | Sell |
616
-892
| -59% | -$10.3K | ﹤0.01% | 3473 |
|
|
2014
Q3 | $19 | Buy |
+1,508
| New | +$22.7K | ﹤0.01% | 3444 |
|
Other funds holding DRNA
Manulife (Manufacturers Life Insurance)'s DRNA Position: Q4 2021 in Review
Manulife (Manufacturers Life Insurance) sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 36,401 shares — an estimated $734K sold.
Manulife (Manufacturers Life Insurance) first reported a position in DRNA in Q3 2014 and held it in 28 quarters. The position peaked at $1.46M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Manulife (Manufacturers Life Insurance) reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 36,401 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $734K.
- Manulife (Manufacturers Life Insurance) first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2014 and held it in 28 quarters.
- Manulife (Manufacturers Life Insurance)'s Dicerna Pharmaceuticals, Inc. position peaked at $1.46M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2021, filed 16 Feb 2022.